Literature DB >> 11226851

Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth.

N Høiby1, H Krogh Johansen, C Moser, Z Song, O Ciofu, A Kharazmi.   

Abstract

The biofilm mode of growth is the survival strategy of environmental bacteria like Pseudomonas aeruginosa. Such P. aeruginosa biofilms also occur in the lungs of chronically infected cystic fibrosis patients, where they protect the bacteria against antibiotics and the immune response. The lung tissue damage is due to immune complex mediated chronic inflammation dominated by polymorphonuclear leukocytes releasing proteases and oxygen radicals.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11226851     DOI： 10.1016/s1286-4579(00)01349-6

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  96 in total

1.  Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors.

Authors:  Morten Hentzer; Hong Wu; Jens Bo Andersen; Kathrin Riedel; Thomas B Rasmussen; Niels Bagge; Naresh Kumar; Mark A Schembri; Zhijun Song; Peter Kristoffersen; Mike Manefield; John W Costerton; Søren Molin; Leo Eberl; Peter Steinberg; Staffan Kjelleberg; Niels Høiby; Michael Givskov
Journal:  EMBO J       Date:  2003-08-01       Impact factor: 11.598

2.  Self-generated diversity produces "insurance effects" in biofilm communities.

Authors:  Blaise R Boles; Matthew Thoendel; Pradeep K Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-16       Impact factor: 11.205

3.  Interference Competition Among Household Strains of Pseudomonas.

Authors:  Michael T France; Susanna K Remold
Journal:  Microb Ecol       Date:  2015-08-16       Impact factor: 4.552

4.  Antimicrobial peptoids are effective against Pseudomonas aeruginosa biofilms.

Authors:  Rinki Kapoor; Mayken W Wadman; Michelle T Dohm; Ann M Czyzewski; Alfred M Spormann; Annelise E Barron
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

5.  Mechanism of fibroblast inflammatory responses to Pseudomonas aeruginosa elastase.

Authors:  Ali O Azghani; Kourtney Neal; Steven Idell; Rodolfo Amaro; Jason W Baker; Abdelwahab Omri; Usha R Pendurthi
Journal:  Microbiology (Reading)       Date:  2014-01-02       Impact factor: 2.777

6.  Pseudomonas aeruginosa lasR mutant fitness in microoxia is supported by an Anr-regulated oxygen-binding hemerythrin.

Authors:  Michelle E Clay; John H Hammond; Fangfang Zhong; Xiaolei Chen; Caitlin H Kowalski; Alexandra J Lee; Monique S Porter; Thomas H Hampton; Casey S Greene; Ekaterina V Pletneva; Deborah A Hogan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-24       Impact factor: 11.205

7.  Rhamnolipid but not motility is associated with the initiation of biofilm seeding dispersal of Pseudomonas aeruginosa strain PA17.

Authors:  Jingjing Wang; Bing Yu; Deying Tian; Ming Ni
Journal:  J Biosci       Date:  2013-03       Impact factor: 1.826

8.  Conditions associated with the cystic fibrosis defect promote chronic Pseudomonas aeruginosa infection.

Authors:  Benjamin J Staudinger; Jocelyn Fraga Muller; Skarphéðinn Halldórsson; Blaise Boles; Angus Angermeyer; Dao Nguyen; Henry Rosen; Olafur Baldursson; Magnús Gottfreðsson; Guðmundur Hrafn Guðmundsson; Pradeep K Singh
Journal:  Am J Respir Crit Care Med       Date:  2014-04-01       Impact factor: 21.405

9.  Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.

Authors:  Xavier Mulet; María D Maciá; Ana Mena; Carlos Juan; José L Pérez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

10.  Cell death in Pseudomonas aeruginosa biofilm development.

Authors:  Jeremy S Webb; Lyndal S Thompson; Sally James; Tim Charlton; Tim Tolker-Nielsen; Birgit Koch; Michael Givskov; Staffan Kjelleberg
Journal:  J Bacteriol       Date:  2003-08       Impact factor: 3.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.